MI more prevalent in heart patients after orthopedic surgery

New research suggests that the incidence of myocardial ischemia (MI) after a major orthopedic surgery among patients with cardiac risk factors is more likely.

The study, published in HSS Journal, showed that patients with higher postoperative cTnI levels were more likely to experience cardiac complications following hip or knee replacement surgery and spinal fusions.

"Cardiovascular events are the most serious complications after major orthopedic surgeries, and patients with myocardial ischemia are at significant risk," said lead author Michael K. Urban, MD, PhD, a physician at the Hospital for Special Surgery (HSS) in New York, in a statement. "We recommend measuring levels of a cardiac protein, troponin, which is released into the blood during cardiac injury. Identifying patients with elevated troponin levels, allows us to intervene to prevent further cardiac events to improve outcome and reduce the overall cost of care."

The data also showed spinal fusions were the most dangerous for heart patients, putting them at nearly four times the risk of cardiac events compared with joint replacement procedures.

In one year, more than 10,600 inpatient orthopedic procedures were performed at HSS and more than 800 patients were identified as at risk for postoperative myocardial ischemia. About 90 percent of myocardial ischemic events happened by the third day after surgery.

"As demand for orthopedic surgery continues to rise, it is imperative that we identify more effective and efficient ways to reduce post-surgical complications," Urban said. "We believe measuring troponin levels in high-risk patients after orthopedic surgery can advance the management of patients with heart disease and reduce complications."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."